Janet Woodcock, MD

Acting Commissioner, U.S. Food and Drug Administration

FDA Acting Commissioner during 2021; recipient of Sen. Johnson oversight letters on COVID-19 vaccine safety surveillance, hot lots, and adverse event reports.

← All people

Timeline appearances (4)

  • oversight

    Sens. Johnson and Lee write to CDC Director Walensky and FDA Acting Commissioner Woodcock raising concerns about reports of adverse events following COVID-19 vaccination.

  • oversight

    Sen. Johnson writes to Collins, Walensky, and Woodcock about vaccine safety monitoring systems described in the October 2020 VRBAC meeting.

  • oversight

    Sen. Johnson writes to Collins, Walensky, Woodcock, Marks, and Shimabukuro about federal safety surveillance systems and reports of adverse events following COVID-19 vaccination.

  • oversight

    Sen. Johnson writes to Woodcock and Walensky about specific "hot lots" of COVID-19 vaccines associated with increased reports of adverse events.